Grey M et al. |
Acceleration of α-synuclein aggregation by exosomes. |
2015 |
J. Biol. Chem. |
pmid:25425650
|
Vite CH et al. |
Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease. |
2015 |
Sci Transl Med |
pmid:25717099
|
Walia JS et al. |
Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates. |
2015 |
Mol. Ther. |
pmid:25515709
|
Li Q et al. |
Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma. |
2015 |
Cancer Sci. |
pmid:25421609
|
Bisel B et al. |
GM1 and GM2 gangliosides: recent developments. |
2014 |
Biomol Concepts |
pmid:25372744
|
Prendergast J et al. |
Ganglioside regulation of AMPA receptor trafficking. |
2014 |
J. Neurosci. |
pmid:25253868
|
Abalem MF et al. |
Fundus autofluorescence in Tay-Sachs disease. |
2014 |
JAMA Ophthalmol |
pmid:24852271
|
Vachalová I et al. |
Anti-GM2, -GD1a and -GD1b positive purely isolated facial diplegia. |
2014 |
Clin Neurol Neurosurg |
pmid:24813327
|
Krishnamoorthy KS et al. |
Case records of the Massachusetts General Hospital. Case 14-2014. An 11-month-old girl with developmental delay. |
2014 |
N. Engl. J. Med. |
pmid:24806163
|
Fuller M et al. |
Liquid chromatography/electrospray ionisation-tandem mass spectrometry quantification of GM2 gangliosides in human peripheral cells and plasma. |
2014 |
Anal. Biochem. |
pmid:24769373
|
Kang S et al. |
Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells. |
2014 |
Gene |
pmid:24534465
|
Tarhini AA et al. |
Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfa. |
2014 |
Melanoma Res. |
pmid:24509407
|
Cachón-González MB et al. |
Reversibility of neuropathology in Tay-Sachs-related diseases. |
2014 |
Hum. Mol. Genet. |
pmid:24057669
|
Okawa S et al. |
Tolosa-hunt syndrome associated with cytomegalovirus infection. |
2013 |
Intern. Med. |
pmid:23676602
|
Eggermont AM et al. |
Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial. |
2013 |
J. Clin. Oncol. |
pmid:24019551
|
Li Y et al. |
Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway. |
2013 |
Int. J. Biochem. Cell Biol. |
pmid:23968914
|
Sato K et al. |
Chemical synthesis of biologically active monoglycosylated GM2-activator protein analogue using N-sulfanylethylanilide peptide. |
2013 |
Angew. Chem. Int. Ed. Engl. |
pmid:23765733
|
Li Y et al. |
Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling. |
2013 |
Mol. Cell. Biochem. |
pmid:23749170
|
Woods AS et al. |
Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury. |
2013 |
ACS Chem Neurosci |
pmid:23590251
|
Rupp A et al. |
Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. |
2013 |
J. Peripher. Nerv. Syst. |
pmid:23521648
|